BACKGROUND: Kisspeptin peptides are critical in human reproductive physiology and are potential therapies for infertility. Kisspeptin-10 stimulates gonadotropin release in both male and female rodents. However, few studies have investigated the effects of kisspeptin-10 on gonadotropin release in humans, and none have investigated the effect in women. If kisspeptin is to be useful for treating reproductive disease, its effects in both men and women must be established. AIM: To compare the effects of kisspeptin-10 administration on reproductive hormone release in healthy men and women. METHODS: Intravenous bolus kisspeptin-10 was administered to men and women (n = 4-5 per group). Subcutaneous bolus and i.v. infusion of kisspeptin-10 was also administered to female women (n = 4-5 per group). Circulating reproductive hormones were measured. RESULTS: In healthy men, serum LH and FSH were elevated after i.v. bolus kisspeptin-10, at doses as low as 0.3 and 1.0 nmol/kg, respectively. In healthy women during the follicular phase of the menstrual cycle, no alterations in serum gonadotropins were observed after i.v. bolus, s.c. bolus, or i.v. infusion of kisspeptin-10 at maximal doses of 10 nmol/kg, 32 nmol/kg, and 720 pmol/kg/min, respectively. In women during the preovulatory phase, serum LH and FSH were elevated after i.v. bolus kisspeptin-10 (10 nmol/kg). CONCLUSION: Kisspeptin-10 stimulates gonadotropin release in men as well as women during the preovulatory phase of menstrual cycle but fails to stimulate gonadotropin release in women during the follicular phase. The sexual dimorphism of the responsiveness of healthy men and women to kisspeptin-10 administration has important clinical implications for the potential of kisspeptin-10 to treat disorders of reproduction.
BACKGROUND: Kisspeptin peptides are critical in human reproductive physiology and are potential therapies for infertility. Kisspeptin-10 stimulates gonadotropin release in both male and female rodents. However, few studies have investigated the effects of kisspeptin-10 on gonadotropin release in humans, and none have investigated the effect in women. If kisspeptin is to be useful for treating reproductive disease, its effects in both men and women must be established. AIM: To compare the effects of kisspeptin-10 administration on reproductive hormone release in healthy men and women. METHODS: Intravenous bolus kisspeptin-10 was administered to men and women (n = 4-5 per group). Subcutaneous bolus and i.v. infusion of kisspeptin-10 was also administered to female women (n = 4-5 per group). Circulating reproductive hormones were measured. RESULTS: In healthy men, serum LH and FSH were elevated after i.v. bolus kisspeptin-10, at doses as low as 0.3 and 1.0 nmol/kg, respectively. In healthy women during the follicular phase of the menstrual cycle, no alterations in serum gonadotropins were observed after i.v. bolus, s.c. bolus, or i.v. infusion of kisspeptin-10 at maximal doses of 10 nmol/kg, 32 nmol/kg, and 720 pmol/kg/min, respectively. In women during the preovulatory phase, serum LH and FSH were elevated after i.v. bolus kisspeptin-10 (10 nmol/kg). CONCLUSION: Kisspeptin-10 stimulates gonadotropin release in men as well as women during the preovulatory phase of menstrual cycle but fails to stimulate gonadotropin release in women during the follicular phase. The sexual dimorphism of the responsiveness of healthy men and women to kisspeptin-10 administration has important clinical implications for the potential of kisspeptin-10 to treat disorders of reproduction.
Authors: Waljit S Dhillo; Owais B Chaudhri; Michael Patterson; Emily L Thompson; Kevin G Murphy; Michael K Badman; Barbara M McGowan; Vian Amber; Sejal Patel; Mohammad A Ghatei; Stephen R Bloom Journal: J Clin Endocrinol Metab Date: 2005-09-20 Impact factor: 5.958
Authors: Michael S Irwig; Gregory S Fraley; Jeremy T Smith; Blake V Acohido; Simina M Popa; Matthew J Cunningham; Michelle L Gottsch; Donald K Clifton; Robert A Steiner Journal: Neuroendocrinology Date: 2005-01-05 Impact factor: 4.914
Authors: Timothy J Greives; Alex O Mason; Melissa-Ann L Scotti; Jacob Levine; Ellen D Ketterson; Lance J Kriegsfeld; Gregory E Demas Journal: Endocrinology Date: 2006-12-21 Impact factor: 4.736
Authors: Muhammad Shahab; Claudio Mastronardi; Stephanie B Seminara; William F Crowley; Sergio R Ojeda; Tony M Plant Journal: Proc Natl Acad Sci U S A Date: 2005-01-31 Impact factor: 11.205
Authors: A Caraty; J T Smith; D Lomet; S Ben Saïd; A Morrissey; J Cognie; B Doughton; G Baril; C Briant; I J Clarke Journal: Endocrinology Date: 2007-08-16 Impact factor: 4.736
Authors: M L Gottsch; M J Cunningham; J T Smith; S M Popa; B V Acohido; W F Crowley; S Seminara; D K Clifton; R A Steiner Journal: Endocrinology Date: 2004-06-24 Impact factor: 4.736
Authors: Suresh Ramaswamy; Stephanie B Seminara; Clifford R Pohl; Meloni J DiPietro; William F Crowley; Tony M Plant Journal: Endocrinology Date: 2007-04-05 Impact factor: 4.736
Authors: Zhongfa Liu; Chen Ren; William Jones; Ping Chen; Stephanie B Seminara; Yee-Ming Chan; Nicola F Smith; Joseph M Covey; Jeffrey Wang; Kenneth K Chan Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2013-03-04 Impact factor: 3.205